2015 Publications


Strong expression of EZH2 and accumulation of trimethylated H3K27 in diffuse large B-cell lymphoma independent of cell of origin and EZH2 codon 641 mutation

Zhou, Z; Gao, J; Popovic, R; Wolniak, K; Parimi; Winter, JN; Licht, JD; Chen, YH.

Leuk Lymphoma, 56 (10), pp. 2895-2901, 2015.
10.3109/10428194.2015.1006220
Pubmed https://www.ncbi.nlm.nih.gov/pubmed/25651430



GLI2-dependent c-MYC upregulation mediates resistance of pancreatic cancer cells to the BET bromodomain inhibitor JQ1

Kumar, K; Raza, SS; Knab, LM; Chow, CR; Kwok, B; Bentrem, DJ; Popovic, R; Ebine, K; Licht, JD; Munshi, HG.

Sci Rep, 5 (0), pp. 9489, 2015.
10.1038/srep09489
Pubmed https://www.ncbi.nlm.nih.gov/pubmed/25807524



Unabridged Analysis of Human Histone H3 by Differential Top-Down Mass Spectrometry Reveals Hypermethylated Proteoforms from MMSET/NSD2 Overexpression

Zheng, Y; Fornelli, L; Compton, PS, Sharma, S; Canterbury, J; Mullen, C; Zarbroushov, Fellers, RT; Thomas, PM; Licht, JD; Senko, MW; Kelleher, NL.

Mol Cell Proteomics, 15 (3), pp. 776-90, 2015.
10.1074/mcp.M115.053819
Pubmed https://www.ncbi.nlm.nih.gov/pubmed/26272979



Deregulation of the Ras-Erk Signaling Axis Modulates the Enhancer Landscape

Nabet, B; Broin, PÓ; Reyes, JM; Shieh, K; Lin CY; Will, CM; Popovic, R; Ezponda, T; Bradner, JE; Golden, AA; Licht, JD.

Cell Rep, 12 (8), pp. 1300-1313, 2015.
10.1016/j.celrep.2015.06.078
Pubmed https://www.ncbi.nlm.nih.gov/pubmed/26279576



DNA Methylation Inhibitors in Cancer Therapy: The Immunity Dimension

Licht, JD.

Cell, 162 (5), pp. 938-939, 2015.
10.1016/j.cell.2015.08.005
Pubmed https://www.ncbi.nlm.nih.gov/pubmed/26317460